Literature DB >> 12175308

Effects of exposure to low-dose-rate (60)co gamma rays on human tumor cells in vitro.

Catherine R Mitchell1, Melvyn Folkard, Michael C Joiner.   

Abstract

Cells of three asynchronously growing human tumor cell lines, PC3 (human prostate carcinoma), T98G and A7 (human glioblastomas), which have been shown previously to demonstrate low-dose hyper-radiosensitivity to low acute single doses, were irradiated with (60)Co gamma rays at low dose rates (2 cGy-1 Gy h(-1)). Instead of a dose-rate sparing response, these cell lines demonstrated an inverse dose-rate effect on cell survival at dose rates below 1 Gy h(-1), whereby a decrease in dose rate resulted in an increase in cell killing per unit dose. A hyper-radiosensitivity-negative cell line, U373MG, did not demonstrate an inverse dose-rate effect. Analysis of the cell cycle indicated that this inverse dose-rate effect was not due to accumulation of cells in G(2)/M phase or to other cell cycle perturbations. T98G cells in reversible G(1)-phase arrest also showed an inverse dose-rate effect at dose rates below 30 cGy h(-1) but a sparing effect as the dose rate was reduced from 60 to 30 cGy h(-1). We conclude that this inverse dose-rate effect in continuous exposures reflects the hyper-radiosensitivity seen in the same cell lines in response to very small acute single doses.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12175308     DOI: 10.1667/0033-7587(2002)158[0311:eoetld]2.0.co;2

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  19 in total

1.  Radiation dose-rate effects, endogenous DNA damage, and signaling resonance.

Authors:  Michael M Vilenchik; Alfred G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-08       Impact factor: 11.205

2.  Non-problematic risks from low-dose radiation-induced DNA damage clusters.

Authors:  Daniel P Hayes
Journal:  Dose Response       Date:  2008-01-16       Impact factor: 2.658

3.  Chloroquine improves survival and hematopoietic recovery after lethal low-dose-rate radiation.

Authors:  Yiting Lim; Mohammad Hedayati; Akil A Merchant; Yonggang Zhang; Hsiang-Hsuan M Yu; Michael B Kastan; William Matsui; Theodore L Deweese
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-03-22       Impact factor: 7.038

4.  Low-dose radiation hyper-radiosensitivity in multicellular tumour spheroids.

Authors:  D Guirado; M Aranda; M Ortiz; J A Mesa; L I Zamora; E Amaya; M Villalobos; A M Lallena
Journal:  Br J Radiol       Date:  2012-10       Impact factor: 3.039

5.  Development and characterization of a novel variable low dose-rate irradiator for in vivo mouse studies.

Authors:  Werner Olipitz; Sheena Hembrador; Matthew Davidson; Jacquelyn C Yanch; Bevin P Engelward
Journal:  Health Phys       Date:  2010-05       Impact factor: 1.316

6.  Combined low dose radio- and radioimmunotherapy of experimental HeLa Hep 2 tumours.

Authors:  David Eriksson; Homa Mirzaie Joniani; Ali Sheikholvaezin; Per-Olov Löfroth; Lennart Johansson; Katrine Riklund Ahlström; Torgny Stigbrand
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-04-30       Impact factor: 9.236

7.  RadNuc: a graphical user interface to deliver dose rate patterns encountered in nuclear medicine with a 137Cs irradiator.

Authors:  Jordan B Pasternack; Roger W Howell
Journal:  Nucl Med Biol       Date:  2012-12-21       Impact factor: 2.408

8.  Requirements regarding dose rate and exposure time for killing of tumour cells in beta particle radionuclide therapy.

Authors:  Jörgen Carlsson; Veronika Eriksson; Bo Stenerlöw; Hans Lundqvist
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-05-23       Impact factor: 9.236

9.  Dose calculations for [(131)i] meta-iodobenzylguanidine-induced bystander effects.

Authors:  M D Gow; C B Seymour; M Boyd; R J Mairs; W V Prestiwch; C E Mothersill
Journal:  Dose Response       Date:  2013-05-30       Impact factor: 2.658

10.  Radioactive ¹²⁵I seed inhibits the cell growth, migration, and invasion of nasopharyngeal carcinoma by triggering DNA damage and inactivating VEGF-A/ERK signaling.

Authors:  Yunhong Tian; Qiang Xie; Yunming Tian; Ying Liu; Zuoping Huang; Cundong Fan; Bing Hou; Dan Sun; Kaitai Yao; Tianfeng Chen
Journal:  PLoS One       Date:  2013-09-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.